US2013137135A1PendingUtilityA1
Compositions and methods for leukocyte differential counting
Est. expiryNov 28, 2031(~5.4 yrs left)· nominal 20-yr term from priority
G01N 21/6428G01N 21/6486G01N 21/05G01N 2021/0346G01N 2021/6482G01N 2021/6441
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provide compositions and methods for classifying leukocytes in a leukocyte population using fluorescence detection. The methods include contacting a leukocyte population in a sample having one or more leukocyte types with a diagnostic composition, exciting the leukocyte population with a light source; and measuring emitted light from each of the one or more leukocyte types to classify the leukocyte population.
Claims
exact text as granted — not AI-modified1 . A diagnostic composition, said diagnostic composition comprising:
a first dye having a cationic charge; a second dye having less of a cationic charge compared to said first dye; and a third dye being reactive to a protein, having an affinity to a protein or having an anionic charge.
2 . The diagnostic composition of claim 1 , wherein said first dye has at least two cationic charges.
3 . The diagnostic composition of claim 1 , wherein said second dye has one cationic charge.
4 . The diagnostic composition of claim 2 , wherein said first dye is propidium iodide.
5 . The diagnostic composition of claim 3 , wherein said second dye is Basic Orange 21.
6 . The diagnostic composition of claim 1 , wherein said third dye is fluorescein isothiocyanate.
7 . A method for classifying leukocytes in a leukocyte population with fluorescence detection, said method comprising:
contacting a leukocyte population in a sample having one or more leukocyte types with a diagnostic composition, said diagnostic composition comprising: a first dye having a cationic charge; a second dye having less cationic charge compared to said first dye; and a third dye being reactive to a protein, having an affinity to a protein or having an anionic charge to stain the leukocyte population to form a stained leukocyte population; exciting the stained leukocyte population with a light source; and measuring emitted light from each of the one or more leukocyte types to classify the leukocyte population.
8 . The method for classifying of claim 7 , wherein the number of leukocyte types in the leukocyte population is a member selected from the group consisting of 2, 3, 4 or 5 leukocyte types.
9 . The method for classifying of claim 8 , wherein the fluorescence emitted from each of the leukocyte types is distinguishable from each of the other types in the population.
10 . The method for classifying of claim 7 , wherein the leukocytes in the population comprise a lymphocyte, a monocyte, a neutrophil, an eosinophil and a basophil.
11 . The method for classifying of claim 7 , wherein the first dye primarily stains the nucleus of the one or more leukocyte types.
12 . The method for classifying of claim 7 , wherein the second dye primarily stains the cytoplasm of the one or more leukocyte types.
13 . The method for classifying of claim 7 , wherein the third dye primarily stains the protein content of the one or more leukocyte types.
14 . The method for classifying of claim 7 , wherein the excitation light is emitted from a source selected from the group consisting of a diode laser, a light emitting diode (LED), an ion laser, a dye laser, and a lamp.
15 . The method for classifying of claim 14 , wherein the emitted light is measured at a first wavelength and at a second wavelength to achieve two color fluorescence measurements.
16 . The method for classifying of claim 15 , wherein the first wavelength is at about 510 nm to about 560 nm.
17 . The method for classifying of claim 15 , wherein the second excitation light is emitted at about 590 nm to about 650 nm.
18 . The method for classifying of claim 15 , wherein the emitted light is measured at the first and the second wavelength.
19 . The method for classifying of claim 18 , wherein the emitted light is measured simultaneously by two photomultiplier tubes.
20 . The method for classifying of claim 7 , wherein the sample is selected from the group consisting of whole blood, plasma, and serum.
21 - 31 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.